Proliferation of double negative (DN) gammadelta T cells in reseponse to allogeneic MHC antigen.
双阴性 (DN) gammadelta T 细胞响应同种异体 MHC 抗原而增殖。
基本信息
- 批准号:02670206
- 负责人:
- 金额:$ 1.47万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1990
- 资助国家:日本
- 起止时间:1990 至 1991
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1. In TL transgenic mouse strain C3H.Tg.Tla^a-3.1, gammadelta T cells start to increase from three weeks after birth and reach to about 30% of total T cells in peripheral lymphoid tisene. It was demonstrated that gammadelta T cells in these mice respond to proliferate in stimulation with immobilized anti-TCR delta mAb.2. Spleen cells from C3H.Tg.Tla^a-3.1 mice proliferated in response to mitomycin C (MMC) treated BALB/c stimulator cells. In these cultures, proliferative response was observed with gammadelta as well as alphabeta T cells. However, when alphabeta T cells were eliminated before MLC, no prolifenation was observed with gammadelta T cells. Thus, proliferative response of gammadelta T cells was dependent on alphabeta T cells. gammadelta T cells recovered after MLR culture showed no cytotoxicity against ^<51>Cr-labeled BALB/c target cells.
1.在TL转基因小鼠品系C3H.Tg.Tla^a-3.1中,Gammadelta T细胞在出生后3周开始增加,约占外周淋巴T细胞总数的30%。研究表明,这些小鼠体内的Gammadelta T细胞在固定化的抗TCR Delta单抗的刺激下产生增殖反应。丝裂霉素C(MMC)刺激BALB/c小鼠后,C3H.Tg.Tla^a-3.1小鼠脾细胞增殖。在这些培养物中,观察到Gammadelta和Alphabeta T细胞的增殖反应。然而,当在MLC之前消除Alphabeta T细胞时,并没有观察到Gammadelta T细胞的增殖。因此,Gammadelta T细胞的增殖反应依赖于Alphabeta T细胞。经MLR培养后恢复的Gammadelta T细胞对标记的BALB/c靶细胞无细胞毒作用。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yamamoto,H.et al.: "Roles of CD8^+ and CD4^+ cells in islet allograft rejection" Transplantation. 50. 120-125 (1990)
Yamamoto,H.et al.:“CD8^ 和 CD4^ 细胞在胰岛同种异体移植排斥中的作用”移植。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
三重野政広: "細胞傷害性CD4^-CD8^-TCRαβT細胞" 臨床免疫. 24. 1440-1447 (1992)
Masahiro Mieno:“细胞毒性 CD4^-CD8^-TCRαβT 细胞”临床免疫学 24. 1440-1447 (1992)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mieno, M., Suto, R., Obata, Y., Udono, H., Takahashi, T., Shiku, H., and Nakayama, E.: "CD4 CD8 T cell receptor alphabeta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic t
Mieno, M.、Suto, R.、Obata, Y.、Udono, H.、Takahashi, T.、Shiku, H. 和 Nakayama, E.:“CD4 CD8 T 细胞受体 Alphata T 细胞:in 的产生
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAKAYAMA Eiichi其他文献
NAKAYAMA Eiichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAKAYAMA Eiichi', 18)}}的其他基金
Use of long overlapping peptides for cancer vaccine and Treg control for potentiating immune response
使用长重叠肽用于癌症疫苗和 Treg 控制以增强免疫反应
- 批准号:
22300332 - 财政年份:2010
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of human tumor antigens and immune responses in patients
人类肿瘤抗原和患者免疫反应分析
- 批准号:
17016048 - 财政年份:2005
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Tumor immune escape and the role of CD4 regulatory T cells
肿瘤免疫逃逸和CD4调节性T细胞的作用
- 批准号:
13670319 - 财政年份:2001
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tumor immune escape by immunoregulatory CD4 T cells
免疫调节 CD4 T 细胞的肿瘤免疫逃逸
- 批准号:
10670304 - 财政年份:1998
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Induction of immune response against MHC class I-binding peptides
诱导针对 MHC I 类结合肽的免疫应答
- 批准号:
07670372 - 财政年份:1995
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cellular mechanisms of graft rejection mediated by CD4-CD8-TCR alphabeta T cells.
CD4-CD8-TCR Alphata T 细胞介导的移植物排斥的细胞机制。
- 批准号:
04454210 - 财政年份:1992
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Operating Grants
Mitochondria regulates peripheral CD4 CD8 double negative T cells function
线粒体调节外周CD4 CD8双阴性T细胞功能
- 批准号:
23K19469 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Mechanism of double-negative T cells in antitumor immunity to breast cancer
双阴性T细胞在乳腺癌抗肿瘤免疫中的作用机制
- 批准号:
10735679 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
498857 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Operating Grants
Double negative regulation of ERK activity by dual-specificity phosphatases and its role in melanomagenesis
双特异性磷酸酶对 ERK 活性的双重负调节及其在黑色素瘤发生中的作用
- 批准号:
21K06892 - 财政年份:2021
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Expansion of CD4+ cytotoxic T lymphocytes and IgD-CD27- double negative B cells in COVID-19 and autoimmune diseases including IgG4-related disease
COVID-19 和自身免疫性疾病(包括 IgG4 相关疾病)中 CD4 细胞毒性 T 淋巴细胞和 IgD-CD27-双阴性 B 细胞的扩增
- 批准号:
21KK0163 - 财政年份:2021
- 资助金额:
$ 1.47万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))
Origin and Function of Double Negative T cells in Lupus
狼疮双阴性 T 细胞的起源和功能
- 批准号:
10304940 - 财政年份:2020
- 资助金额:
$ 1.47万 - 项目类别:
Computer simulation of double-negative acoustic metamaterial composites
双负声学超材料复合材料的计算机模拟
- 批准号:
20K11848 - 财政年份:2020
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Double Negative T Cell: “Off-the-Shelf” Allogeneic CAR T Cell Platform for T Cell Malignancies
双阴性 T 细胞:用于 T 细胞恶性肿瘤的“现成”同种异体 CAR T 细胞平台
- 批准号:
449714 - 财政年份:2020
- 资助金额:
$ 1.47万 - 项目类别:
Studentship Programs
Origin and Function of Double Negative T cells in Lupus
狼疮双阴性 T 细胞的起源和功能
- 批准号:
10512753 - 财政年份:2020
- 资助金额:
$ 1.47万 - 项目类别: